
CLOVER HEALTH INVESTMENTS CO
CLOVNASDAQTrading Snapshot
- Day Range
- $4.39 β $4.50
- 52-Week Range
- $1.58 β $5.59
- Volume
- $5.56B
- Avg Volume
- $3.72B
- Shares Outstanding
- 526.7M
- Next Earnings
- Sep 21, 2026
Fundamentals Snapshot
- Annual Revenue
- $1.92B
- Last Q Revenue
- $743M
- P/E Ratio
- β
- P/S Ratio
- 1.1x
- EPS (TTM)
- $-0.11
- Dividend Yield
- β
Why Investors Own CLOV
- βHigh-growth profile β revenue up +21.1% YoY with expanding US Equity exposure.
- βHealthy economics β 33% gross margin and 16% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About CLOVER HEALTH INVESTMENTS CO
Clover Health Investments, Corp. is a U.S.-based firm specializing in Medicare Advantage insurance. The company leverages its proprietary software platform, the Clover Assistant, to provide both Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) health plans for individuals eligible for Medicare. In addition to its insurance operations, Clover Health also engages in non-insurance-related business ventures. The company was established in 2014 and its main office is located in Franklin, Tennessee.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
CLOVER HEALTH INVESTMENTS CO tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift CLOV price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
CLOVER HEALTH INVESTMENTS CO announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.